A drug used alone or with other drugs to treat adults and children aged 1 year and older with certain types of chronic myeloid leukemia or acute lymphoblastic leukemia that are Philadelphia chromosome positive. US Brand Name(s): Sprycel. FDA Approved Yes
Are you looking for or in search of FDA approved “sacituzumab govitecan-hziy for injection in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Breast Cancer. Need Access of sacituzumab govitecan-hziy injection, get in touch with our healthcare professional.
Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+). It is taken by mouth.
Dasatinib was approved for medical use in the United States and in the European Union in 2006. It is on the World Health Organization’s List of Essential Medicines.
Dasatinib is approved to treat:
Acute lymphoblastic leukemia that is Philadelphia chromosome positive.
Chronic myelogenous leukemia (CML) that is Philadelphia chromosome positive.